| Complete immunization (n=731) | Age appropriate immunization at | ||||
---|---|---|---|---|---|---|
12 months (n=731) | 24 months (n=704) | |||||
 | OR (95% CI) | p | OR (95% CI) | p | OR (95% CI) | p |
Actual age | 0.77 (0.65-0.91) | 0.002 | 0.47 (0.35-0.64) | <0.001 | 0.45 (0.29-0.71) | 0.001 |
Father’s nationality | ||||||
Other | Reference | |||||
Greek | 1.29 (0.88-1.90) | 0.188 | 2.10(0.91-4.86) | 0.082 | 2.95 (0.91-9.50) | 0.071 |
Number of children | ||||||
1 | Reference | |||||
2 | 0.91 (0.64-1.31) | 0.621 | 0.58 (0.31-1.09) | 0.092 | 0.41 (0.19-0.90) | 0.026 |
3+ | 0.77 (0.48-1.22) | 0.265 | 0.42 (0.18-1.01) | 0.053 | 0.27 (0.08-0.89) | 0.031 |
Maternal education | ||||||
≤12 years | Reference | |||||
>13 years | 0.73 (0.53-1.02) | 0.061 | 0.68 (0.38-1.22) | 0.198 | 0.42 (0.19-0.94) | 0.035 |
Use of multivalent vaccines | ||||||
≤ 4-valent | Reference | |||||
5- or 6-valent | 1.09 (0.78-1.50) | 0.630 | 3.46 (1.51-7.92) | 0.003 | 2.24 (0.88-5.68) | 0.090 |
Impact of insurance reimbursement on the decision to vaccinate | ||||||
No | Reference | |||||
Yes | 0.95 (0.67-1.34) | 0.764 | 1.22 (0.65-2.28) | 0.538 | 1.28 (0.57-2.90) | 0.551 |
Place of vaccination | ||||||
Privately | Reference | |||||
Insurance clinic / Public health clinic | 1.39 (0.95-2.03) | 0.086 | 0.64 (0.32-1.30) | 0.216 | 0.56 (0.23-1.36) | 0.199 |
Type of insurance | ||||||
IKA | Reference | |||||
Other | 1.13 (0.77-1.66) | 0.545 | 1.67 (0.84-3.34) | 0.144 | 1.69 (0.70-4.11) | 0.244 |